104 related articles for article (PubMed ID: 26022121)
1. Delivery of human NKG2D-IL-15 fusion gene by chitosan nanoparticles to enhance antitumor immunity.
Yan C; Jie L; Yongqi W; Weiming X; Juqun X; Yanbing D; Li Q; Xingyuan P; Mingchun J; Weijuan G
Biochem Biophys Res Commun; 2015 Jul; 463(3):336-43. PubMed ID: 26022121
[TBL] [Abstract][Full Text] [Related]
2. Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.
Tan L; Han S; Ding S; Xiao W; Ding Y; Qian L; Wang C; Gong W
Int J Nanomedicine; 2017; 12():3095-3107. PubMed ID: 28450784
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a fusion protein of the extracellular domains of NKG2D to IL-15 retards colon cancer growth in mice.
Xia Y; Chen B; Shao X; Xiao W; Qian L; Ding Y; Ji M; Gong W
J Immunother; 2014 Jun; 37(5):257-66. PubMed ID: 24810637
[TBL] [Abstract][Full Text] [Related]
4. Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.
Chen Y; Chen B; Yang T; Xiao W; Qian L; Ding Y; Ji M; Ge X; Gong W
Cell Mol Immunol; 2017 Mar; 14(3):293-307. PubMed ID: 26364916
[TBL] [Abstract][Full Text] [Related]
5. NKG2D-IL-15 fusion protein encapsulated in N-[(2-hydroxy-3-trimethylammonium) propyl] chitosan chloride retards melanoma growth in mice.
Chen R; Ding Y; Xi J; Lu G; Xiao W; Ding Y; Qian L; Lin Z; Gong W
Transl Cancer Res; 2019 Oct; 8(6):2230-2241. PubMed ID: 35116976
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
7. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
[TBL] [Abstract][Full Text] [Related]
8. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
[TBL] [Abstract][Full Text] [Related]
9. Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
Yao W; Peng Y; Du M; Luo J; Zong L
Mol Pharm; 2013 Aug; 10(8):2904-14. PubMed ID: 23768205
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
Kawakami K; Terabe M; Kawakami M; Berzofsky JA; Puri RK
Cancer Res; 2006 Apr; 66(8):4434-42. PubMed ID: 16618770
[TBL] [Abstract][Full Text] [Related]
13. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
[TBL] [Abstract][Full Text] [Related]
14. Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
Hu Z; Chen J; Zhou S; Yang N; Duan S; Zhang Z; Su J; He J; Zhang Z; Lu X; Zhao Y
Theranostics; 2017; 7(7):1942-1952. PubMed ID: 28638480
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.
Huang T; Song X; Jing J; Zhao K; Shen Y; Zhang X; Yue B
J Nanobiotechnology; 2018 Jan; 16(1):8. PubMed ID: 29378591
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells.
Malakooty Poor E; Baghaban Eslaminejad M; Gheibi N; Bagheri F; Atyabi F
Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):376-84. PubMed ID: 24001051
[TBL] [Abstract][Full Text] [Related]
17. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response.
Li A; Qin L; Wang W; Zhu R; Yu Y; Liu H; Wang S
Biomaterials; 2011 Jan; 32(2):469-77. PubMed ID: 20934217
[TBL] [Abstract][Full Text] [Related]
18. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects.
Kang TH; Mao CP; He L; Tsai YC; Liu K; La V; Wu TC; Hung CF
PLoS One; 2012; 7(4):e35141. PubMed ID: 22509395
[TBL] [Abstract][Full Text] [Related]
20. Systemically administered gp100 encoding DNA vaccine for melanoma using water-in-oil-in-water multiple emulsion delivery systems.
Kalariya M; Amiji MM
Int J Pharm; 2013 Sep; 453(2):400-7. PubMed ID: 23702000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
